DIVIDENDS RANKING

Highest Dividend yield of Pharmaceuticals and Biotechnology stocks




A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

11-30-2016

Dividend yield of Pharmaceuticals and Biotechnology companies ordered from highest ( 1.67% average).

Company Dividend Payout Country
GlaxoSmithKline5.35%43.24%UK
AstraZeneca4.82%80.00%UK
Novo-Nordisk B3.95%66.76%Denmark
Sanofi3.85%53.47%France
Takeda Pharm3.84%177.01%Japan
Novartis (REGD)3.84%32.69%Switzerland
AbbVie Inc3.75%66.28%USA
Pfizer3.73%67.80%USA
Teva Pharmaceutical3.67%56.51%Israel
Roche Hldgs (GENUS)3.57%66.37%Switzerland
Orion B3.24%87.25%Finland
Lilly (Eli) & Co3.04%74.18%USA
Merck & Co3.01%55.93%USA
Johnson & Johnson2.88%53.06%USA
Amgen Corp2.78%35.90%USA
Daiichi Sankyo2.73%44.50%Japan
Abbott Laboratories2.73%47.27%USA
Bristol Myers Squibb2.69%144.76%USA
Gilead Sciences2.55%13.27%USA
KYORIN Holdings2.41%31.09%Japan
Kaken Pharmaceutical2.35%27.73%Japan
Eisai2.27%17.02%Japan
Mitsubishi Tanabe Ph2.23%47.73%Japan
Miraca Holdings2.19%-125.71%Japan
Otsuka Holdings2.15%64.28%Japan
Sawai Pharmaceutical2.12%27.77%Japan
Astellas Pharmaceuti2.09%29.68%Japan
Tsumura & Co2.07%36.02%Japan
Grifols S.A. Cl B2.06%13.30%Spain
Shanghai Pharmaceuti2.00%35.14%China
TORRENT PHARMACEUTIC1.91%23.68%India
Alfresa Holdings1.87%21.13%Japan
Santen Pharm1.86%17.86%Japan
Medipal Holdings1.83%21.96%Japan
UCB Cap1.81%43.48%Belgium and Lux.
CSL1.74%44.53%Australia
Mochida Pharm1.73%33.56%Japan
China Medical System1.69%45.83%China
Kissei Pharm1.68%27.05%Japan
China Traditional Ch1.66%31.58%China
Grifols1.66%22.14%Spain
Chugai Seiyaku1.62%45.36%Japan
Suzuken1.58%18.49%Japan
Shanghai Fosun Pharm1.55%35.51%China
Kyowa Hakko Kirin1.53%45.90%Japan
Ono Pharmaceutical1.50%75.60%Japan
Novozymes A/S1.47%33.72%Denmark
Hisamitsu Pharmaceut1.46%38.25%Japan
Wockhardt1.43%32.47%India
Lonza Grp Ag N1.38%39.65%Switzerland
Recordati1.36%31.82%Italy
Chr. Hansen Holding1.35%44.19%Denmark
Hikma Pharmaceutical1.35%30.67%UK
Sinopharm Group (H)1.33%29.63%China
Ipsen1.33%34.27%France
CSPC Pharmaceutical1.32%37.93%China
Kalbe Farma1.27%43.69%Indonesia
Shionogi1.26%31.75%Japan
Rohto Pharmaceutical1.24%23.93%Japan
Richter1.23%20.42%Hungary
Merck Kgaa1.11%21.78%Germany
Sino Biopharm (P Chi1.03%20.83%China
Piramal Enterprises1.03%27.19%India
Taisho Pharmaceutica1.02%35.39%Japan
Yuhan1.02%16.22%Korea
Kobayashi Pharmaceut0.98%29.30%Japan
Sumitomo Dainippon P0.96%23.23%Japan
Aspen Pharmacare Hol0.86%23.10%South Africa
Divis Laboratories0.85%23.80%India
Cadila Healthcare0.80%21.26%India
Actelion Hldg N0.77%24.63%Switzerland
China National Accor0.75%14.29%China
Zoetis0.75%40.86%USA
Luye Pharma Group (P0.71%14.29%China
Perrigo Company plc0.67%10.21%USA
Hanmi Science0.65%15.27%Korea
Dr Reddys Labs0.63%14.55%India
Nippon Shinyaku0.60%33.90%Japan
Hanmi Pharmaceutical0.53%11.45%Korea
Lupin0.50%14.54%India
Shire0.40%14.18%UK
Aurobindo Pharmaceut0.36%7.64%India
Cipla0.35%10.34%India
Glenmark Pharmaceuti0.23%6.73%India
Sun Pharmaceuticals0.14%4.81%India
Qiagen Nv0.00%0.00%Germany
Valeant Pharmaceutic0.00%0.00%Canada
3SBio (P Chip)0.00%0.00%China
Guangzhou Baiyunsha0.00%0.00%China
Genmab0.00%0.00%Denmark
H. Lundbeck0.00%0.00%Denmark
Peptidream0.00%0.00%Japan
Celltrion Inc0.00%0.00%Korea
Samsung Biologics0.00%0.00%Korea
OBI Pharma0.00%0.00%Taiwan
Alexion Pharm0.00%0.00%USA
Alkermes plc0.00%0.00%USA
Allergan0.00%0.00%USA
Alnylam Pharmaceutic0.00%0.00%USA
Biogen0.00%0.00%USA
BioMarin Pharm0.00%0.00%USA
Celgene Corp0.00%0.00%USA
Endo International p0.00%0.00%USA
Illumina Inc0.00%0.00%USA
Incyte0.00%0.00%USA
Jazz Pharmaceuticals0.00%0.00%USA
Mallinckrodt plc0.00%0.00%USA
Mylan N.V.0.00%0.00%USA
Quintiles Transnatio0.00%0.00%USA
Regeneron Phar0.00%0.00%USA
Vertex Pharm0.00%0.00%USA
Medivation0.00%0.00%USA
Adcock Ingram Holdin2.74%88.51%South Africa
Meda A1.57%21.55%Sweden
GlaxoSmithKline Phar1.51%111.59%India

 


 

All rights reserved

 information advertisement legal

Dividends Ranking | Firm Report | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.